Pancuronium bromide and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pancuronium bromide (pancuronium bromide) and Decadron (dexamethasone). Common drug interactions include dysgeusia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Pancuronium bromide and Decadron. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Pancuronium bromide?

Pancuronium bromide has active ingredients of pancuronium bromide. eHealthMe is studying from 666 Pancuronium bromide users. Check the latest studies of Pancuronium bromide.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 19, 2026

11 people who take Pancuronium bromide and Decadron together, and have interactions are studied.

Pancuronium bromide and Decadron drug interactions.

What are the common drug interactions of Pancuronium Bromide and Decadron, by gender? *:

female:

  1. Dysgeusia (disorder of the sense of taste)
  2. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  3. Erythema multiforme (a type of hypersensitivity reaction)
  4. Flushing (the warm, red condition of human skin)
  5. Injection site reaction
  6. Interstitial lung disease
  7. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Streptococcal infection

male:

  1. Anxiety
  2. Emotional distress
  3. Death
  4. Multi-organ failure (multisystem organ failure)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Fear
  8. Pain
  9. Renal impairment (severely reduced kidney function)
  10. Renal injury (kidney injury)

What are the common drug interactions of Pancuronium Bromide and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dysgeusia (disorder of the sense of taste)
  2. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  3. Erythema multiforme (a type of hypersensitivity reaction)
  4. Flushing (the warm, red condition of human skin)
  5. Injection site reaction
  6. Interstitial lung disease
  7. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  8. Respiratory failure (inadequate gas exchange by the respiratory system)
  9. Stomatitis (inflammation of mucous membrane of mouth)
  10. Streptococcal infection

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal impairment (severely reduced kidney function)

60+:

  1. Anxiety
  2. Emotional distress
  3. Renal failure (kidney dysfunction)
  4. Multi-organ failure (multisystem organ failure)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Fear
  7. Pain
  8. Renal impairment (severely reduced kidney function)
  9. Renal injury (kidney injury)
  10. Stress

What are the existing conditions these people have? *

  1. Postoperative Wound Infection: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Pancuronium bromide and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pancuronium bromide and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pancuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pancuronium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pancuronium bromide and dexamethasone (the active ingredients of Pancuronium bromide and Decadron, respectively), and Pancuronium bromide and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: